Open AccessCombination of hydroquinone and fractional CO2 laser versus hydroquinone monotherapy in melasma treatment: A randomized, single-blinded, split-face clinical trial
Author(s) -
Sanaz Nourmohammadi Abadchi,
Farahnaz Fatemi Naeini,
Elham Beheshtian
Publication year - 2019
Publication title -
indian journal of dermatology/indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/ijd.ijd_240_17
Subject(s) - melasma , medicine , hyperpigmentation , hydroquinone , randomized controlled trial , laser therapy , combination therapy , patient satisfaction , clinical trial , blinded study , dermatology , clinical study , laser , surgery , chemistry , physics , organic chemistry , optics
Melasma is a chronic hyperpigmentation skin disorder mainly affecting women in the reproductive age. Available treatments for melasma do not lead to long-term satisfactory results.